Title: Tasisulam sodium (LY573636 sodium) as third-line treatment in patients with unresectable, metastatic non-small-cell lung cancer: a phase-II study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20120601
Title: A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors.
Journal: Cancer chemotherapy and pharmacology 20111101
Title: Tasisulam sodium, an antitumor agent that inhibits mitotic progression and induces vascular normalization.
Journal: Molecular cancer therapeutics 20111101
Title: Novel acyl sulfonamide LY573636-sodium: effect on hematopoietic malignant cells.
Journal: Oncology reports 20081101
